Kidney Transplant Infection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-20Clinical Trial Update: Reduction of BK Viremia in Kidney Transplant Patients [NA]
This clinical trial update indicates the study on reducing BK viremia in kidney transplant patients has been withdrawn.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Torque Teno Virus: A Biomarker of Immunosuppression
An update on a completed clinical trial evaluating Torque Teno Virus as a biomarker of immunosuppression in kidney transplant recipients, wi…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
This ClinicalTrials.gov entry describes an ongoing single-center prospective cohort study evaluating immune monitoring in kidney transplant …
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: PRObiotics for KIdney Transplantation [NA]
A clinical trial update shows enrollment by invitation for a study using probiotics in kidney transplant recipients to address urinary tract…
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study [Phase 4]
A Phase 4 pilot study evaluated quinolone prophylaxis to prevent BK virus infection in kidney transplant recipients; results completed and p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection [Phase 2]
Phase 2 trial suggesting conversion to Envarsus post-kidney transplant may reduce BK infection risk.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients. [Phase 4]
Phase 4 clinical trial evaluating a food supplement for preventing urinary tract infections in kidney transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus [Phase 3]
Phase 3 trial comparing brincidofovir to valganciclovir for prevention of cytomegalovirus in transplant patients; study terminated with post…
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring. [Phase 2]
Phase 2 clinical trial investigating γδ T cell immunomonitoring for secondary prophylaxis of CMV disease in kidney transplant patients has c…
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation [Phase 4]
Phase 4 trial update on grazoprevir/elbasvir for genotype 1b chronic hepatitis C after liver or kidney transplantation; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin. [Phase 3]
Phase 3 randomized trial evaluating valganciclovir prophylaxis in CMV-seropositive kidney transplant patients to influence thymoglobulin-ind…
-
CLINICAL_TRIALS trial_result · 2019-07-12Clinical Trial Update: Transplantation Using Hepatitis C Positive Donors, A Safety Trial [Phase 3]
Phase 3 safety trial exploring transplantation using hepatitis C positive donors; results and status are unknown.